NDC 68788-7000

Fenofibrate

Fenofibrate

Fenofibrate is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is Fenofibrate.

Product ID68788-7000_ba86b7dc-6e1c-4e99-a755-3e49833e9ca7
NDC68788-7000
Product TypeHuman Prescription Drug
Proprietary NameFenofibrate
Generic NameFenofibrate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2006-05-10
Marketing CategoryANDA / ANDA
Application NumberANDA076635
Labeler NamePreferred Pharmaceuticals Inc.
Substance NameFENOFIBRATE
Active Ingredient Strength160 mg/1
Pharm ClassesPeroxisome Proliferator Receptor alpha Agonist [EPC]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 68788-7000-6

60 TABLET, FILM COATED in 1 BOTTLE (68788-7000-6)
Marketing Start Date2017-07-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68788-7000-3 [68788700003]

Fenofibrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA076635
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-07-24
Marketing End Date2019-09-18

NDC 68788-7000-1 [68788700001]

Fenofibrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA076635
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-07-24
Marketing End Date2019-09-18

NDC 68788-7000-6 [68788700006]

Fenofibrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA076635
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-07-24
Marketing End Date2019-09-18

NDC 68788-7000-9 [68788700009]

Fenofibrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA076635
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-07-24
Marketing End Date2019-09-18

Drug Details

Active Ingredients

IngredientStrength
FENOFIBRATE160 mg/1

OpenFDA Data

SPL SET ID:ba86b7dc-6e1c-4e99-a755-3e49833e9ca7
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 349287

    • Pharmacological Class

    • Peroxisome Proliferator Receptor alpha Agonist [EPC]

    NDC Crossover Matching brand name "Fenofibrate" or generic name "Fenofibrate"

    NDCBrand NameGeneric Name
    0093-7755FenofibrateFenofibrate
    0093-7756FenofibrateFenofibrate
    0115-0511FenofibrateFENOFIBRATE
    0115-0522FenofibrateFENOFIBRATE
    0115-0533FenofibrateFENOFIBRATE
    0115-1522FenofibrateFenofibrate
    0115-1523FenofibrateFenofibrate
    0115-5511FENOFIBRATEFENOFIBRATE
    0115-5522FENOFIBRATEFENOFIBRATE
    68071-2021FenofibrateFenofibrate
    68071-1601FenofibrateFenofibrate
    68071-2135FenofibrateFenofibrate
    68071-3300FenofibrateFenofibrate
    68071-3114fenofibratefenofibrate
    68071-2042FenofibrateFenofibrate
    68071-2115FenofibrateFenofibrate
    68071-4264FenofibrateFenofibrate
    68071-4289FenofibrateFenofibrate
    68071-4297FenofibrateFenofibrate
    68071-4320fenofibratefenofibrate
    68071-4310FenofibrateFenofibrate
    68071-4486FenofibrateFenofibrate
    68071-4088FenofibrateFenofibrate
    68071-4182fenofibratefenofibrate
    68071-4265fenofibratefenofibrate
    68071-4692FenofibrateFenofibrate
    68071-4557FENOFIBRATEFENOFIBRATE
    68071-4358fenofibratefenofibrate
    68071-4659FenofibrateFenofibrate
    68084-636FenofibrateFenofibrate
    68084-328FENOFIBRATEFENOFIBRATE
    68084-827FENOFIBRATEFENOFIBRATE
    68084-329FenofibrateFenofibrate
    68084-635FenofibrateFenofibrate
    68084-835FenofibrateFenofibrate
    68151-4717FenofibrateFenofibrate
    68151-4718FenofibrateFenofibrate
    68180-130FenofibrateFenofibrate
    68180-131FenofibrateFenofibrate
    68180-360FenofibrateFenofibrate
    68180-363FenofibrateFenofibrate
    68180-362FenofibrateFenofibrate
    68180-361FenofibrateFenofibrate
    68382-270FenofibrateFenofibrate
    68382-269FenofibrateFenofibrate
    68462-581fenofibratefenofibrate
    68462-582fenofibratefenofibrate
    68462-580fenofibratefenofibrate
    68788-7000FenofibrateFenofibrate
    68788-6330FenofibrateFenofibrate
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.